NO963254D0 - Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler - Google Patents

Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler

Info

Publication number
NO963254D0
NO963254D0 NO963254A NO963254A NO963254D0 NO 963254 D0 NO963254 D0 NO 963254D0 NO 963254 A NO963254 A NO 963254A NO 963254 A NO963254 A NO 963254A NO 963254 D0 NO963254 D0 NO 963254D0
Authority
NO
Norway
Prior art keywords
pct
hiv
macrocyclic
useful
antivirals
Prior art date
Application number
NO963254A
Other languages
English (en)
Norwegian (no)
Other versions
NO963254L (no
Inventor
Robert Allan Farr
Brent Ludvick Podlogar
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO963254L publication Critical patent/NO963254L/no
Publication of NO963254D0 publication Critical patent/NO963254D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO963254A 1994-02-04 1996-08-02 Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler NO963254D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19208094A 1994-02-04 1994-02-04
PCT/US1994/013711 WO1995021186A1 (en) 1994-02-04 1994-11-28 Macrocyclic difluorostatone derivatives useful as antiviral agents

Publications (2)

Publication Number Publication Date
NO963254L NO963254L (no) 1996-08-02
NO963254D0 true NO963254D0 (no) 1996-08-02

Family

ID=22708156

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963254A NO963254D0 (no) 1994-02-04 1996-08-02 Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler

Country Status (20)

Country Link
US (1) US5969132A (de)
EP (1) EP0742791B1 (de)
JP (1) JP3574455B2 (de)
KR (1) KR100367379B1 (de)
CN (1) CN1142830A (de)
AT (1) ATE198602T1 (de)
AU (1) AU684875B2 (de)
CA (1) CA2182476C (de)
DE (1) DE69426574T2 (de)
DK (1) DK0742791T3 (de)
ES (1) ES2155515T3 (de)
FI (1) FI963073A0 (de)
GR (1) GR3035623T3 (de)
HU (1) HUT74384A (de)
IL (1) IL112514A0 (de)
NO (1) NO963254D0 (de)
NZ (1) NZ277410A (de)
PT (1) PT742791E (de)
WO (1) WO1995021186A1 (de)
ZA (1) ZA95756B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1633774T3 (da) 2003-06-18 2010-05-25 Tranzyme Pharma Inc Makrocykliske motilinreceptorantagonister

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672792A5 (de) * 1985-02-19 1989-12-29 Sandoz Ag
FI865196A7 (fi) * 1985-04-19 1986-12-18 Upjohn Co Halostatiinisubstituoituja reniini-inhibiittoreita.
FI910084A7 (fi) * 1988-07-08 1991-01-07 Smithkline Beckman Corp Retroviraalisia proteaaseja sitovia peptidejä
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
EP0565631B1 (de) * 1991-01-02 1996-09-18 Merrell Pharmaceuticals Inc. Antivirale verbindungen
AU711035B2 (en) * 1994-07-15 1999-10-07 Merrell Pharmaceuticals Inc. Difluorostatone antiviral agents

Also Published As

Publication number Publication date
CN1142830A (zh) 1997-02-12
ATE198602T1 (de) 2001-01-15
KR100367379B1 (ko) 2003-04-11
HUT74384A (en) 1996-12-30
WO1995021186A1 (en) 1995-08-10
PT742791E (pt) 2001-06-29
FI963073L (fi) 1996-08-02
EP0742791A1 (de) 1996-11-20
EP0742791B1 (de) 2001-01-10
JP3574455B2 (ja) 2004-10-06
ES2155515T3 (es) 2001-05-16
GR3035623T3 (en) 2001-06-29
AU684875B2 (en) 1998-01-08
FI963073A7 (fi) 1996-08-02
NO963254L (no) 1996-08-02
US5969132A (en) 1999-10-19
AU1262295A (en) 1995-08-21
NZ277410A (en) 1997-02-24
HU9602158D0 (en) 1996-09-30
JPH09508417A (ja) 1997-08-26
FI963073A0 (fi) 1996-08-02
DK0742791T3 (da) 2001-04-02
CA2182476C (en) 2000-12-26
DE69426574D1 (de) 2001-02-15
DE69426574T2 (de) 2001-08-09
IL112514A0 (en) 1995-05-26
ZA95756B (en) 1995-10-05

Similar Documents

Publication Publication Date Title
ES2139195T3 (es) Derivados de sulfonamidas como inhibidores de la aspartil-proteasa.
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
CY1107626T1 (el) Παραγωγα πυραζολιου για την θεραπεια του hiv
NO20075806L (no) Aminosyrehydroksyetylaminosulfonamid retrovirale proteaseinhibitorer
AP9600827A0 (en) Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease.
LV12719A (lv) Benzoxazinones as inhibitors of hiv reverse transcriptase
ATE229945T1 (de) Zur behandlung von cmv infektionen geeignete 1,3, 4-thiadiazole
NZ306026A (en) N-[2-hydroxy-3-sulphonyl-amino]-3-(hydrocarbylsulphonyl)hydrocarbyl-amide derivatives
BR9607625A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
CA2195125A1 (en) Difluorostatone antiviral agents
ES2123156T3 (es) Compuestos y procedimientos de inhibicion de hiv y virus semejantes.
FI911875A0 (fi) Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen.
NO963254D0 (no) Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
BR0213741A (pt) composto e composição antiretrovirais

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application